Royal Bank of Canada’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $825K | Buy |
267,187
+204,942
| +329% | +$633K | ﹤0.01% | 3751 |
|
2025
Q1 | $218K | Buy |
62,245
+28,249
| +83% | +$98.9K | ﹤0.01% | 4293 |
|
2024
Q4 | $111K | Buy |
33,996
+17,621
| +108% | +$57.5K | ﹤0.01% | 4813 |
|
2024
Q3 | $63K | Sell |
16,375
-60,413
| -79% | -$232K | ﹤0.01% | 5127 |
|
2024
Q2 | $237K | Buy |
76,788
+3,642
| +5% | +$11.2K | ﹤0.01% | 4250 |
|
2024
Q1 | $188K | Sell |
73,146
-34,073
| -32% | -$87.6K | ﹤0.01% | 4309 |
|
2023
Q4 | $268K | Sell |
107,219
-8,955
| -8% | -$22.4K | ﹤0.01% | 4324 |
|
2023
Q3 | $236K | Buy |
116,174
+106,409
| +1,090% | +$216K | ﹤0.01% | 4177 |
|
2023
Q2 | $22K | Sell |
9,765
-82,014
| -89% | -$185K | ﹤0.01% | 5697 |
|
2023
Q1 | $277K | Sell |
91,779
-2,064
| -2% | -$6.23K | ﹤0.01% | 3999 |
|
2022
Q4 | $218K | Buy |
93,843
+1,302
| +1% | +$3.03K | ﹤0.01% | 4344 |
|
2022
Q3 | $177K | Sell |
92,541
-30,426
| -25% | -$58.2K | ﹤0.01% | 4396 |
|
2022
Q2 | $334K | Sell |
122,967
-7,208
| -6% | -$19.6K | ﹤0.01% | 3963 |
|
2022
Q1 | $388K | Sell |
130,175
-17,915
| -12% | -$53.4K | ﹤0.01% | 4026 |
|
2021
Q4 | $576K | Buy |
148,090
+3,653
| +3% | +$14.2K | ﹤0.01% | 3847 |
|
2021
Q3 | $620K | Buy |
144,437
+85,542
| +145% | +$367K | ﹤0.01% | 3707 |
|
2021
Q2 | $179K | Buy |
58,895
+58,317
| +10,089% | +$177K | ﹤0.01% | 4694 |
|
2021
Q1 | $2K | Sell |
578
-14,798
| -96% | -$51.2K | ﹤0.01% | 6709 |
|
2020
Q4 | $55K | Buy |
15,376
+1,497
| +11% | +$5.36K | ﹤0.01% | 5071 |
|
2020
Q3 | $43K | Buy |
13,879
+5,610
| +68% | +$17.4K | ﹤0.01% | 4922 |
|
2020
Q2 | $15K | Buy |
8,269
+5,856
| +243% | +$10.6K | ﹤0.01% | 5207 |
|
2020
Q1 | $3K | Buy |
2,413
+1,130
| +88% | +$1.41K | ﹤0.01% | 5660 |
|
2019
Q4 | $3K | Sell |
1,283
-5,969
| -82% | -$14K | ﹤0.01% | 5856 |
|
2019
Q3 | $11K | Buy |
7,252
+642
| +10% | +$974 | ﹤0.01% | 5114 |
|
2019
Q2 | $14K | Buy |
6,610
+39
| +0.6% | +$83 | ﹤0.01% | 5071 |
|
2019
Q1 | $23K | Sell |
6,571
-202
| -3% | -$707 | ﹤0.01% | 4835 |
|
2018
Q4 | $26K | Sell |
6,773
-4,283
| -39% | -$16.4K | ﹤0.01% | 4734 |
|
2018
Q3 | $104K | Buy |
11,056
+2,983
| +37% | +$28.1K | ﹤0.01% | 4241 |
|
2018
Q2 | $60K | Sell |
8,073
-6,926
| -46% | -$51.5K | ﹤0.01% | 4493 |
|
2018
Q1 | $75K | Buy |
14,999
+4,104
| +38% | +$20.5K | ﹤0.01% | 4249 |
|
2017
Q4 | $55K | Buy |
10,895
+540
| +5% | +$2.73K | ﹤0.01% | 4388 |
|
2017
Q3 | $64K | Sell |
10,355
-3,500
| -25% | -$21.6K | ﹤0.01% | 4543 |
|
2017
Q2 | $50K | Sell |
13,855
-125
| -0.9% | -$451 | ﹤0.01% | 4387 |
|
2017
Q1 | $46K | Sell |
13,980
-7,250
| -34% | -$23.9K | ﹤0.01% | 4530 |
|
2016
Q4 | $52K | Buy |
21,230
+8,280
| +64% | +$20.3K | ﹤0.01% | 4482 |
|
2016
Q3 | $45K | Sell |
12,950
-240
| -2% | -$834 | ﹤0.01% | 4461 |
|
2016
Q2 | $46K | Sell |
13,190
-400
| -3% | -$1.4K | ﹤0.01% | 4477 |
|
2016
Q1 | $56K | Sell |
13,590
-1,860
| -12% | -$7.66K | ﹤0.01% | 4386 |
|
2015
Q4 | $68K | Sell |
15,450
-54,850
| -78% | -$241K | ﹤0.01% | 4440 |
|
2015
Q3 | $428K | Buy |
70,300
+2,240
| +3% | +$13.6K | ﹤0.01% | 3133 |
|
2015
Q2 | $808K | Buy |
68,060
+35,133
| +107% | +$417K | ﹤0.01% | 2691 |
|
2015
Q1 | $575K | Buy |
32,927
+3,802
| +13% | +$66.4K | ﹤0.01% | 2951 |
|
2014
Q4 | $442K | Buy |
29,125
+13,075
| +81% | +$198K | ﹤0.01% | 3171 |
|
2014
Q3 | $340K | Sell |
16,050
-17,540
| -52% | -$372K | ﹤0.01% | 3299 |
|
2014
Q2 | $439K | Buy |
33,590
+13,560
| +68% | +$177K | ﹤0.01% | 3079 |
|
2014
Q1 | $430K | Buy |
20,030
+1,900
| +10% | +$40.8K | ﹤0.01% | 3005 |
|
2013
Q4 | $144K | Hold |
18,130
| – | – | ﹤0.01% | 3768 |
|
2013
Q3 | $127K | Sell |
18,130
-780
| -4% | -$5.46K | ﹤0.01% | 3800 |
|
2013
Q2 | $88K | Buy |
+18,910
| New | +$88K | ﹤0.01% | 3805 |
|